Drugs made of mRNA have the potential to transform medicine—if only they could get into cells in one piece. Now, University of Connecticut researchers have shown that packaging mRNA like a virus could ...

Kymera Therapeutics develops targeted protein degradation therapies for immunology, oncology, and fibrosis using proprietary technology.

Discover six RNAi biotech companies helping to drive momentum in a field that can precisely target disease at its genetic root.

The most reliable method is a short, realistic check of your usual intake. Choose 2–3 typical days (training and non-training ...

Net cash used in operating and investing activities was $23.3 million and $163.7 million for the fourth quarter and full year ...

Sheep farmers are often cautious about adopting total mixed ration feeding, in the belief that a manufactured compound is ...